# Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:

> **NCT03709992** · NA · SUSPENDED · sponsor: **Mansoura University** · enrollment: 200 (estimated)

## Conditions studied

- Ureter Stone
- Quality of Life
- Ureter Obstruction

## Interventions

- **DRUG:** Trospium Chloride
- **DRUG:** Tamsulosin

## Key facts

- **NCT ID:** NCT03709992
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-12-18
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-11-01
- **Target enrollment:** 200 (ESTIMATED)
- **Why stopped:** Because of COVID-19 Crisis
- **Last updated:** 2023-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03709992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03709992, "Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03709992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*